about
Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: implications for targeted EZH2 inhibitor therapy?Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitorActivating somatic mutations in diffuse large B-cell lymphomas: lessons from next generation sequencing and key elements in the precision medicine era.Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma.Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.Application of the cghRA framework to the genomic characterization of Diffuse Large B-Cell Lymphoma.Oncogenic events rather than antigen selection pressure may be the main driving forces for relapse in diffuse large B-cell lymphomas.Digital PCR for quantification of recurrent and potentially actionable somatic mutations in circulating free DNA from patients with diffuse large B-cell lymphoma.A lowered 26S proteasome activity correlates with mantle lymphoma cell lines resistance to genotoxic stress.Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma.Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis.Determination of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Reverse Transcriptase Multiplex Ligation-Dependent Probe Amplification Classifier: A CALYM Study.Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing.Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study.Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases.New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes.Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphomaMultiplexed targeted sequencing of recurrent fusion genes in acute leukaemiaAuthors' ReplySomatic mutations of cell-free circulating DNA detected by targeted next-generation sequencing and digital droplet PCR in classical Hodgkin lymphomaNon-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohortRefining diffuse large B-cell lymphoma subgroups using integrated analysis of molecular profilesReverse transcriptase multiplex ligation-dependent probe amplification in endomyocardial biopsies for the diagnosis of cardiac allograft rejection
P50
Q36140942-86D99835-4237-48D7-81B9-796EA4D3951DQ36179080-37F8A6DC-C551-4199-B99E-1FA842C32DCDQ38240579-9AC48F7F-6FA4-474B-95B1-52E05162DB34Q38754419-BB2B8F06-27E7-496A-9AB6-40431785508EQ38764010-CC701DF1-033F-4D44-AD9A-AED7865C460CQ38798116-9A627595-BAE4-458F-A8B5-D2A3698161A6Q38811964-3DF4F97C-163C-48F7-82F3-560ADF28BF37Q40353159-DBBDFC39-F2F1-4B6B-B252-FFEAF0C029DEQ41362934-B9D8DDF2-3EFF-4921-B72E-3D08F339482EQ41471491-74C5B5A7-124A-4288-A640-A472A142746FQ42384499-AC1492A8-0573-4A3E-8C50-9AF0B34FC39DQ47605552-6203B5FB-8A6E-4F81-9E67-68475FE7CEB2Q51016381-F8C1A50F-9323-48AA-A816-A5E448B8C709Q52887085-8CAB5520-F357-4CCD-82FF-810EC167AFCEQ52948207-6AD429CB-B140-412F-8F1E-92BA1BCE6EB9Q55508866-4F20310C-4946-49FF-B62E-48DDE204832EQ61053563-FBC444C2-617E-437D-B957-43EB966A8653Q85521108-F6C665FF-F1C3-4B82-B6A4-FC032E8A72F3Q87886421-C05DC81F-61B6-4E22-8936-290A6CABA24FQ90694260-D5FDE073-7B3A-4CCA-8644-3E3D154D1216Q90699429-4460CBD8-8AF0-4B84-AB98-661CFA8888EFQ90928103-26C5D88F-0DCB-44C3-B15E-9C3D0DCAABBFQ91852376-0DBD4972-524F-40DE-952E-46D97A15C225
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Pierre-Julien Viailly
@ast
Pierre-Julien Viailly
@en
Pierre-Julien Viailly
@es
Pierre-Julien Viailly
@nl
type
label
Pierre-Julien Viailly
@ast
Pierre-Julien Viailly
@en
Pierre-Julien Viailly
@es
Pierre-Julien Viailly
@nl
prefLabel
Pierre-Julien Viailly
@ast
Pierre-Julien Viailly
@en
Pierre-Julien Viailly
@es
Pierre-Julien Viailly
@nl
P106
P31
P496
0000-0002-9636-8971